The frontrunners in a crowded race to develop the first respiratory syncytial virus (RSV) vaccine - Pfizer Inc and GSK - will face scrutiny from a panel of experts to the U.S. Food and Drug Administration this week.
"RSV is the last of the great big respiratory viruses that afflict our population on an annual basis," said Dr. William Schaffner, an infectious disease expert at Vanderbilt University Medical Center.
GSK's vaccine was 82.6% effective in preventing lower respiratory tract disease in people aged 60 and over, and 94.1% effective in preventing severe disease.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FDA warns of Guillain-Barre syndrome as possible risk of Pfizer’s RSV vaccineGuillain-Barre syndrome, or inflammatory neuropathy, is a disorder in which the body’s immune system mistakenly attacks the nerves.
Consulte Mais informação »
Doctors who touted ivermectin as covid fix now pushing it for flu, RSVFirst, the group of doctors championed ivermectin as a covid panacea. It failed to live up to the hype. Now, they’re promoting the anti-parasitic to prevent and treat the flu and RSV.
Consulte Mais informação »
A single injection could protect babies against RSV over winterRSV infections kill around 100,000 children each year, but now an antibody injection has proven safe and effective at reducing the risk from the disease.
Consulte Mais informação »
Washington state attorney general says FDA rules on abortion drug are unreasonableA coalition of state attorneys general is suing the Food and Drug Administration over its regulation of mifepristone. NPR's Michel Martin speaks with Washington state Attorney General Bob Ferguson.
Consulte Mais informação »
FDA authorizes combination flu-COVID test for home useWhile at-home COVID tests are readily available, this is the first home test for influenza A and B, commonly known as the flu.
Consulte Mais informação »
FDA authorizes first at-home joint flu, COVID-19 testThe Food and Drug Administration has issued an emergency use authorization for the first over-the-counter at-home test than can detect whether someone has the flu or COVID-19.
Consulte Mais informação »